TIK-301

TIK-301
Clinical data
Other namesBeta-methyl-6-chloromelatonin; LY-156735; PD-6735
Routes of
administration
Oral
Legal status
Legal status
  • Investigational
Pharmacokinetic data
Elimination half-life1 hour
Identifiers
  • N-[(2R)-(6-Chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H17ClN2O2
Molar mass280.75 g·mol−1
3D model (JSmol)
  • C[C@@H](CNC(=O)C)c1c[nH]c2c1cc(c(c2)Cl)OC
  • InChI=1S/C14H17ClN2O2/c1-8(6-16-9(2)18)11-7-17-13-5-12(15)14(19-3)4-10(11)13/h4-5,7-8,17H,6H2,1-3H3,(H,16,18)/t8-/m0/s1 ☒N
  • Key:RKHCTAKUYDTFHE-QMMMGPOBSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

TIK-301 (LY-156735) is an agonist for the melatonin receptors MT1 and MT2 that is under development for the treatment of insomnia and other sleep disorders.[1] Its agonist action on MT1 and MT2 receptors in the suprachiasmatic nucleus in the brain enables its action as a chronobiotic. It is in the same class of melatonin receptor agonists as ramelteon and tasimelteon.

  1. ^ "PD-6735, LY-156735,118702-11-7,C14-H17-Cl-N2-O2,N-[2(R)-(6-C--药物合成数据库". Archived from the original on 2009-09-27.